Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.63 |
| ▸ | GAA | P10253 | 9/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.63 |
| ▸ | GLA | P06280 | 6/20 | 0.63 |
| ▸ | HPGD | P15428 | 6/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.63 |
| ▸ | MEN1 | O00255 | 2/20 | 0.63 |
| ▸ | CASP1 | P29466 | 1/20 | 0.63 |
| ▸ | CASP7 | P55210 | 1/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.63 |
| ▸ | ERN1 | O75460 | 5/20 | 0.63 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.59 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17615428 | 0.96 | ERN1 (0.61) | ALDH1A1GAAKDM4EGLAHPGD | |
| SCHEMBL17615425 | 0.92 | ERN1 (0.66) | ALDH1A1GAAKDM4EGLAHPGD | |
| SCHEMBL17615417 | 0.88 | ERN1 (0.71) | ALDH1A1GAAKDM4EGLAHPGD | |
| SCHEMBL16710500 | 0.84 | GAA (0.69) | ALDH1A1GAAKDM4EGLAHPGD | |
| SCHEMBL31454884 | 0.81 | ALDH1A1 (0.65) | ALDH1A1GAAKDM4EGLAHPGD | |
| SCHEMBL16197777 | 0.79 | ERN1 (0.70) | ALDH1A1GAAKDM4EGLAHPGD | |
| SCHEMBL18074001 | 0.79 | KDM4E (0.62) | ALDH1A1GAAKDM4EGLAHPGD | |
| SCHEMBL14398970 | 0.78 | ERN1 (1.00) | ALDH1A1GAAKDM4EGLAHPGD | |
| SCHEMBL16197973 | 0.76 | ERN1 (0.69) | ALDH1A1GAAKDM4EGLAHPGD | |
| SCHEMBL15295521 | 0.75 | MCL1 (0.70) | ALDH1A1GAAKDM4EGLAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160083361-A1 | INHIBITORS OF THE IRE-1/XBP-1 PATHWAY AND METHODS OF USING THEREOF | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. | 2016-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160083361-A1 | INHIBITORS OF THE IRE-1/XBP-1 PATHWAY AND METHODS OF USING THEREOF | XBP1, RRP1B, ERN1 | ALDH1A1 2009/4885GAA 2533/4885KDM4E 3704/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.